C188-9, a new and effective STAT3 inhibitor targeting SH2 domain, was first reported to inhibit granulocyte-colony stimulating factor (G-CSF)-induced Stat3 phosphorylation and induce apoptosis of acute myeloid leukemia (AML) cell lines and primary samples (11). This evidence concerns the gene STAT3 and acute myeloid leukemia.